Erdafitinib is a pan–fibroblast growth factor receptor (FGFR) inhibitor approved for the treatment of locally advanced or metastatic urothelial carcinoma in adults with susceptible FGFR3/2 alterations ...
Just as no two cancers are the same, treatment isn’t one-size-fits-all — and for one Arizona mother and teacher, personalized chemotherapy became the path to survival. Tammy Morrow, 55, had been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback